DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 39 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $0 | – | 197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 419,942 | $1,869,000 | 0.98% |
| Manatuck Hill Partners, LLC | 570,500 | $2,539,000 | 0.77% |
| Corriente Advisors, LLC | 203,641 | $906,000 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 275,000 | $1,224,000 | 0.40% |
| Ikarian Capital, LLC | 415,000 | $1,847,000 | 0.15% |
| COOPERMAN LEON G | 50,000 | $223,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 46,562 | $207,000 | 0.01% |
| Trexquant Investment LP | 17,019 | $76,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 30,511 | $136,000 | 0.00% |
| MARSHALL WACE, LLP | 155,662 | $693,000 | 0.00% |